|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Watson_for_Pharmaceuticals
|
|
gptkbp:acquired
|
Watson Pharmaceuticals
|
|
gptkbp:acquisition
|
gptkb:collaboration
gptkb:2012
Forest Laboratories
acquired by Teva Pharmaceuticals
|
|
gptkbp:ceo
|
gptkb:Robert_W._Stewart
Brent Saunders
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:employees
|
over 10,000
10,000
|
|
gptkbp:focus_area
|
generic drugs
specialty pharmaceuticals
|
|
gptkbp:founded
|
gptkb:1984
gptkb:2000
|
|
gptkbp:founder
|
gptkb:Sigurdur_Olafsson
|
|
gptkbp:headquarters
|
gptkb:Parsippany-Troy_Hills,_New_Jersey
gptkb:New_Jersey
Parsippany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Actavis, Inc.
|
|
gptkbp:industry
|
gptkb:drug
|
|
gptkbp:invention
|
over 500
|
|
gptkbp:market
|
global
|
|
gptkbp:named_after
|
gptkb:Teva_Pharmaceuticals
gptkb:Allergan,_Inc.
|
|
gptkbp:net_worth
|
$1.2 billion (2014)
|
|
gptkbp:parent_company
|
gptkb:Allergan_plc
|
|
gptkbp:partnerships
|
various universities
|
|
gptkbp:philanthropy
|
Actavis Foundation
|
|
gptkbp:products
|
generic drugs
branded drugs
|
|
gptkbp:research
|
Dr. Paul Bisaro
|
|
gptkbp:research_areas
|
multiple worldwide
|
|
gptkbp:revenue
|
$3.5 billion (2014)
$15.5 billion (2015)
|
|
gptkbp:subsidiary
|
Actavis Pharma, Inc.
|
|
gptkbp:symbol
|
gptkb:ACT
|
|
gptkbp:type
|
gptkb:Company
|
|
gptkbp:website
|
www.actavis.com
|